LIMES Schlosskliniken AG (ETR:LIK)
Germany · Delayed Price · Currency is EUR 520.00
-10.00 (-1.89%)
Sep 16, 2026, 3:18 PM CET
LIMES Schlosskliniken AG Income Statement
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Revenue | 56.72 | 50 | 37.45 | 37.17 | 28.81 | 23.43 |
Other Revenue | - | - | 0 | - | - | - |
| 56.72 | 50 | 37.45 | 37.17 | 28.81 | 23.43 | |
Revenue Growth | 35.46% | 33.49% | 0.76% | 29.04% | 22.92% | 112.74% |
Cost of Revenue | 31 | 27.45 | 20.81 | 20.94 | 15.34 | 13.58 |
Gross Profit | 25.72 | 22.54 | 16.65 | 16.23 | 13.47 | 9.86 |
Selling, General & Admin | 11.14 | 9.15 | 7.3 | 6.82 | 4.06 | 3.66 |
Other Operating Expenses | 1.02 | 0.6 | 2.3 | 1.74 | 0.76 | 0.18 |
Operating Expenses | 16.28 | 13.24 | 12.36 | 11.21 | 7.47 | 5.33 |
Operating Income | 9.44 | 9.31 | 4.29 | 5.03 | 6 | 4.53 |
Interest Expense | -0.42 | -0.23 | -0.15 | -0.44 | -0.39 | -0.22 |
Other Non Operating Income (Expenses) | -0 | - | - | 0 | 0 | -0 |
EBT Excluding Unusual Items | 9.02 | 9.08 | 4.14 | 4.59 | 5.61 | 4.31 |
Pretax Income | 9.02 | 9.08 | 4.14 | 4.59 | 5.61 | 4.31 |
Income Tax Expense | 2.18 | 2.04 | 0.91 | 0.68 | 0.74 | 0.2 |
Earnings From Continuing Operations | 6.84 | 7.04 | 3.23 | 3.91 | 4.86 | 4.11 |
Minority Interest in Earnings | -1.33 | -1.34 | -0.12 | -0.51 | -0.66 | -0.16 |
Net Income | 5.51 | 5.69 | 3.11 | 3.4 | 4.2 | 3.94 |
Net Income to Common | 5.51 | 5.69 | 3.11 | 3.4 | 4.2 | 3.94 |
Net Income Growth | 19.79% | 83.01% | -8.38% | -19.20% | 6.58% | - |
Shares Outstanding (Basic) | 0 | 0 | 0 | 0 | 0 | 0 |
Shares Outstanding (Diluted) | 0 | 0 | 0 | 0 | 0 | 0 |
Shares Change | 2.46% | 1.62% | - | - | - | - |
EPS (Basic) | 18.33 | 19.11 | 10.61 | 11.58 | 14.34 | 13.45 |
EPS (Diluted) | 18.33 | 19.11 | 10.61 | 11.58 | 14.34 | 13.45 |
EPS Growth | 16.92% | 80.09% | -8.38% | -19.20% | 6.58% | - |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | 6.79 | 1.14 | 2.49 | -0.32 | 6.7 | 4.37 |
Free Cash Flow Per Share | 22.62 | 3.82 | 8.51 | -1.08 | 22.85 | 14.92 |
Dividend Per Share | 10.000 | 10.000 | - | - | - | - |
Dividend Growth | - | - | - | - | - | - |
Gross Margin | 45.34% | 45.09% | 44.44% | 43.66% | 46.76% | 42.07% |
Operating Margin | 16.64% | 18.62% | 11.45% | 13.52% | 20.82% | 19.33% |
Profit Margin | 9.71% | 11.39% | 8.31% | 9.14% | 14.59% | 16.83% |
Free Cash Flow Margin | 11.98% | 2.28% | 6.66% | -0.85% | 23.26% | 18.67% |
EBITDA | 13.53 | 12.76 | 7.05 | 7.67 | 8.65 | 6.02 |
EBITDA Margin | 23.86% | 25.53% | 18.82% | 20.64% | 30.04% | 25.67% |
D&A For EBITDA | 4.09 | 3.46 | 2.76 | 2.65 | 2.65 | 1.49 |
EBIT | 9.44 | 9.31 | 4.29 | 5.03 | 6 | 4.53 |
EBIT Margin | 16.64% | 18.62% | 11.45% | 13.52% | 20.82% | 19.33% |
Effective Tax Rate | 24.18% | 22.44% | 21.97% | 14.75% | 13.25% | 4.58% |
Revenue as Reported | 60.71 | 53.95 | 38.12 | 37.96 | 30.05 | 25.23 |